APA

Eigl B. J., Chi K., Tu D., Hotte S. J., Winquist E., Booth C. M., Canil C., Potvin K., Gregg R., North S., Zulfiqar M., Ellard S., Ruether J. D., Le L., Kakumanu A. S., Salim M., Allan A. L., Feilotter H., Theis A. & Seymour L. (2018). A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209. : Oncotarget.

Chicago

Eigl Bernhard Josef, Chi Kim, Tu Dongsheng, Hotte Sebastien J, Winquist Eric, Booth Christopher M, Canil Christina, Potvin Kylea, Gregg Richard, North Scott, Zulfiqar Muhammad, Ellard Susan, Ruether Joseph Dean, Le Lyly, Kakumanu A Saranya, Salim Mohammad, Allan Alison L, Feilotter Harriet, Theis Ashley and Seymour Lesley. 2018. A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209. : Oncotarget.

Harvard

Eigl B. J., Chi K., Tu D., Hotte S. J., Winquist E., Booth C. M., Canil C., Potvin K., Gregg R., North S., Zulfiqar M., Ellard S., Ruether J. D., Le L., Kakumanu A. S., Salim M., Allan A. L., Feilotter H., Theis A. and Seymour L. (2018). A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209. : Oncotarget.

MLA

Eigl Bernhard Josef, Chi Kim, Tu Dongsheng, Hotte Sebastien J, Winquist Eric, Booth Christopher M, Canil Christina, Potvin Kylea, Gregg Richard, North Scott, Zulfiqar Muhammad, Ellard Susan, Ruether Joseph Dean, Le Lyly, Kakumanu A Saranya, Salim Mohammad, Allan Alison L, Feilotter Harriet, Theis Ashley and Seymour Lesley. A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209. : Oncotarget. 2018.